In lung squamous carcinoma or lung adenocarcinoma tissues with mutations in NRAS, KRAS, EGFR, BARF, PIK3CA, EML4-ALK, activation of PI3K/AKT/mTOR pathway and PD-L1 expression can be detected simultaneously 46. This evidence concerns the gene PIK3CA and lung adenocarcinoma.